Stock IRMD IRADIMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus IRADIMED CORPORATION

Equities

IRMD

US46266A1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
41.86 USD +0.94% Intraday chart for IRADIMED CORPORATION +2.10% -11.82%
Apr. 03 IRadimed Files $75 Million Common Stock Shelf Registration MT
Feb. 08 Transcript : IRadimed Corporation, Q4 2023 Earnings Call, Feb 08, 2024

Evolution of the average Target Price on IRADIMED CORPORATION

Price target over the last 5 years

History of analyst recommendation changes

8570.Y_Tr82NZ709KRPOjMzTO3i8GZq-B-QFkKu30SAm9ANA.EKebmSJqmHYPE57UeASc5ltFBPfylEVcaYGMJ336Uo8uhsa7FBOmCCMtnA~52743e7f0a8e41d9f402cc29193c7297

Analyst Recommendations on IRADIMED CORPORATION

Roth Capital Adjusts IRadimed's Price Target to $42 From $36, Maintains Buy Rating MT
IRADIMED : Roth Capital Adjusts iRadimed's Price Target to $36 from $32, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
41.86 USD
Average target price
62.5 USD
Spread / Average Target
+49.31%
High Price Target
65 USD
Spread / Highest target
+55.28%
Low Price Target
60 USD
Spread / Lowest Target
+43.33%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IRADIMED CORPORATION

Roth Capital Partners

Ratings for IRADIMED CORPORATION

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION